Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

Name: Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Published: 2026
License: Public Domain

Delcath Systems Inc. · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

php

metastatic breast cancer in the liver, melphalan, melphalan/hds, melphalan/hepatic delivery system, eribulin, vinorelbine, capecitabine, metastatic breast cancer, mbc, liver dominant disease, hepatic delivery system, php

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 869090
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.